ACT Capital Management »

Day One Biopharmaceuticals I shares owned by ACT Capital Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $120k 13k 9.32

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Day One Biopharmaceuticals I

FMR
BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
Vestal Point Capital
State Street Corporation
Deerfield Management Company
Pictet Asset Management Holding SA
AIGH Capital Management
Geode Capital Management
Hudson Bay Capital Management
Goldman Sachs Group
Qube Research & Technologies
MAK Capital One
Balyasny Asset Management

View all funds holding Day One Biopharmaceuticals I